Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Krystal Biotech (KRYS) over the last 3 years, with Q3 2025 value amounting to $209000.0.

  • Krystal Biotech's Amortizatization of Intangibles rose 1117.02% to $209000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $818000.0, marking a year-over-year increase of 367.55%. This contributed to the annual value of $747000.0 for FY2024, which is 1736.73% down from last year.
  • As of Q3 2025, Krystal Biotech's Amortizatization of Intangibles stood at $209000.0, which was up 1117.02% from $194000.0 recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Amortizatization of Intangibles ranged from a high of $233000.0 in Q4 2023 and a low of $182000.0 during Q1 2024
  • In the last 3 years, Krystal Biotech's Amortizatization of Intangibles had a median value of $209000.0 in 2025 and averaged $207090.9.
  • Per our database at Business Quant, Krystal Biotech's Amortizatization of Intangibles plummeted by 1826.09% in 2024 and then soared by 2307.69% in 2025.
  • Over the past 3 years, Krystal Biotech's Amortizatization of Intangibles (Quarter) stood at $233000.0 in 2023, then decreased by 18.03% to $191000.0 in 2024, then rose by 9.42% to $209000.0 in 2025.
  • Its Amortizatization of Intangibles was $209000.0 in Q3 2025, compared to $194000.0 in Q2 2025 and $224000.0 in Q1 2025.